The Tumor Growth Inhibitory Effect of a Standardized Extract of Cultured <i>Lentinula edodes</i> Mycelia Using Patient Derived Xenograft Model-Reference-Cited by-同舟云学术

The Tumor Growth Inhibitory Effect of a Standardized Extract of Cultured <i>Lentinula edodes</i> Mycelia Using Patient Derived Xenograft Model

Published:2024-02-28 Issue:2 Volume:47 Page:532-538
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Yoshii Remi¹,Adachi Shigeki¹,Ryo Haruko¹,Hatanaka Eiko¹,Yasuda Koujun¹,Kaji Momoyo¹,Enomoto Kumiko¹,Takanari Jun²,Yoshidome Katsuhide³,Nomura Taisei¹⁴,Tomiyama Noriyuki⁵

Affiliation:

1. Nomura Project, National Institutes of Biomedical Innovation, Health and Nutrition

2. Amino Up Co., Ltd.

3. Department of Breast Surgery, Osaka Police Hospital

4. Department of Radiation Biology and Medical Genetics, Graduate School of Medicine, Osaka University

5. Department of Radiology, Graduate School of Medicine, Osaka University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/2/47_b23-00734/_pdf

Reference38 articles.

1. 1) Zhang X, Claerhout S, Prat A, et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res., 73, 4885–4897 (2013).

2. 2) Ohgidani M, Ichihara H, Goto K, Matsumoto Y, Ueoka R. Anticancer effects of residual powder from Barley–Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo. Biol. Pharm. Bull., 35, 984–987 (2012).

3. 3) Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature, 301, 527–530 (1983).

4. 4) Tsujimura A, Fukuhara S, Soda T, Takezawa K, Kiuchi H, Takao T, Miyagawa Y, Nonomura N, Adachi S, Tokita Y, Nomura T. Histologic evaluation of human benign prostatic hyperplasia treated by dutasteride: a study by xenograft model with improved severe combined immunodeficient mice. Urology, 85, 274.e1–8 (2015).

5. 5) Okada S, Vaeteewoottacharn K, Kariya R. Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models. Cells., 8, 889 (2019).